Cytomegalovirus Viral Load and Virus-Specific Immune Reconstitution after Peripheral Blood Stem Cell versus Bone Marrow Transplantation-Reference-Cited by-同舟云学术

Cytomegalovirus Viral Load and Virus-Specific Immune Reconstitution after Peripheral Blood Stem Cell versus Bone Marrow Transplantation

Published:2012-01 Issue:1 Volume:18 Page:66-75
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Guerrero Abraham,Riddell Stanley R.,Storek Jan,Stevens-Ayers Terry,Storer Barry,Zaia John A.,Forman Stephen,Negrin Robert S.,Chauncey Thomas,Bensinger William,Boeckh Michael

Funder

NIH

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference45 articles.

1. Hematopoietic stem cells: source matters;Haspel;Curr Stem Cell Res Ther,2008

2. Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers;Bensinger;N Engl J Med,2001

3. Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: a retrospective comparison with marrow transplantation;Bensinger;Blood,1996

4. Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation;Storek;Blood,2001

5. Improved immune reconstitution after allotransplantation of peripheral blood stem cells instead of bone marrow;Ottinger;Blood,1996

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cytomegalovirus;Remington and Klein's Infectious Diseases of the Fetus and Newborn Infant;2025

2. Naive T Cells in Graft Versus Host Disease and Graft Versus Leukemia: Innocent or Guilty?;Frontiers in Immunology;2022-06-20

3. Effectiveness of prophylactic antiviral therapy in reducing HBV reactivation for HBsAg-positive recipients following allogeneic hematopoietic stem cell transplantation: a multi-institutional experience from an HBV endemic area;Annals of Hematology;2022-01-04

4. Patient risk stratification and tailored clinical management of post‐transplant CMV‐, EBV‐, and BKV‐infections by monitoring virus‐specific T‐cell immunity;eJHaem;2021-06

5. CMV viral load kinetics as surrogate endpoints after allogeneic transplantation;Journal of Clinical Investigation;2021-01-04